Backed by $55 million in funding, scientists build on previous work and broaden exploration on psychedelics for ailment and wellness: (1) to establish new treatment options for a wider variety of psychiatric and behavioral Conditions with the aspiration of treatment options tailored to the specific desires of person sufferers and (two) to broaden�